OpenVSafe by OpenVAERS
Search V-safe

CWK-23439-94318

3 vaccinations 10 coded responses 29 check-ins 10 free-text entries 4 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
981 / WA
Registered
2020-12-31
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
PML-31967-09020 Child or adolescent in my care · Male · 2022-01-28
NSW-19651-91120 Child or adolescent in my care · Male · 2022-01-28
SDX-26157-20090 Child or adolescent in my care · Female · 2022-01-28

Timeline

  1. 2020-12-31
    Registered in v-safe
  2. 2020-12-31
    Dose 1 — Moderna
  3. 2020-12-31
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Conjunctivitis allergic — Feeling: Good · Site: Pain
    Free text: Allergic conjunctivitis
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-07
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-14
    Survey response — day 14, dose 1
    MedDRA: Arthralgia, Injection site reaction, Loss of personal independence in daily activities — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: 5cm itchy rash at injection site (developed on 1/8, eight days after injection) with associated arthralgias that impaired ADLs. Both symptoms lasted 48 hours and resolved.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-14
    Report sent to call center — day 14, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-01-21
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-01-28
    Dose 2 — Moderna
  15. 2021-01-28
    Survey response — day 0, dose 2
    MedDRA: Conjunctivitis allergic — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Allergic conjunctivitis (had this with first shot, too)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Conjunctivitis allergic, Supraventricular tachycardia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: SVT, Allergic conjunctivitis
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Conjunctivitis allergic — Feeling: Fair · Site: Pain · Fatigue or tiredness
    Free text: Allergic conjunctivitis
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Conjunctivitis allergic — Feeling: Good · Fatigue or tiredness
    Free text: Allergic conjunctivitis
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-02-04
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  23. 2021-02-11
    Survey response — day 14, dose 2
    MedDRA: Arthralgia, Lymphadenopathy, Reaction to previous exposure to any vaccine — Feeling: Good
    Free text: Arthralgias (similar to after my first shot) and left axillary adenopathy noted on my mammogram (requires f/u ultrasound). NO delayed onset of rash this time.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-02-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-25
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-03-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-03-08
  28. 2021-03-09
    Call successful
    Participant prefers to complete VAERS report online
  29. 2021-03-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  30. 2021-04-29
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  31. 2021-07-29
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  32. 2021-11-09
    Dose 3 — Moderna
  33. 2022-01-28
    Survey response — 12 months, dose 2
    MedDRA: Urticaria chronic — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Chronic urticaria, continuous since 11/20/2021
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-01-28
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  35. 2022-02-01
    Call successful
    Not applicable - Accidental Reporting
  36. 2022-02-08
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  37. 2022-05-10
    Survey response — 6 months, dose 3
    MedDRA: Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Ongoing hives over my whole body since third covid vaccine in Nov 2021 (6 months now)
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-05-10
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  39. 2022-05-11
  40. 2022-05-11
  41. 2022-05-11
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  42. 2022-11-09
    Survey response — 12 months, dose 3
    MedDRA: Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Continue to have hives since covid booster in Nov 2021 (almost a year ago)
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-11-09
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  44. 2022-11-10
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

DoseDateManufacturerCo-administered
12020-12-31Moderna
22021-01-28Moderna
32021-11-09Moderna No

Call center

4 call center cases

4 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-01

Systemic reaction (other): Allergic conjunctivitis

Release 2 — day 14, dose 1

2021-01-14

Symptoms: 5cm itchy rash at injection site (developed on 1/8, eight days after injection) with associated arthralgias that impaired ADLs. Both symptoms lasted 48 hours and resolved.

Release 2 — day 0, dose 2

2021-01-28

Systemic reaction (other): Allergic conjunctivitis (had this with first shot, too)

Release 3 — days 1–6 daily, dose 2

2021-01-29

Systemic reaction (other): SVT, Allergic conjunctivitis

2021-01-30

Systemic reaction (other): Allergic conjunctivitis

2021-01-31

Systemic reaction (other): Allergic conjunctivitis

Release 4 — day 14, dose 2

2021-02-11

Symptoms: Arthralgias (similar to after my first shot) and left axillary adenopathy noted on my mammogram (requires f/u ultrasound). NO delayed onset of rash this time.

Release 11 — 12 months, dose 2

2022-01-28

Symptoms: Chronic urticaria, continuous since 11/20/2021

Release 11 — 6 months, dose 3

2022-05-10

Symptoms: Ongoing hives over my whole body since third covid vaccine in Nov 2021 (6 months now)

Release 12 — 12 months, dose 3

2022-11-09

Symptoms: Continue to have hives since covid booster in Nov 2021 (almost a year ago)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDInjection site reaction ✓ ✓ ✓
SDLoss of personal independence in daily activities ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDReaction to previous exposure to any vaccine ✓ ✓ ✓
SDUrticaria · · ✓
SDUrticaria chronic · · ✓
SROConjunctivitis allergic ✓ ✓ ✓
SROSupraventricular tachycardia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release